Defining Patient-Centeredness in Healthcare

Published May 21, 2018

ISPOR Special Interest Group Presents Findings and Consensus Definition for “Patient Engagement” and “Patient-Centeredness”

Baltimore, MD, USA—May 21, 2018—ISPOR, the professional society for health economics and outcomes research, held a session this evening, “Defining Patient-Centeredness and Engagement in Health Economics and Outcomes Research: Proposed Definition and Stakeholder Response [F3],” at ISPOR 2018 in Baltimore, MD, USA. Patient-related initiatives in healthcare are expanding as more and more stakeholders seek to involve patients in drug development, research, and delivery of healthcare. The lack of a common definition for the terms “patient engagement” and “patient-centeredness” has made it difficult to quantify and measure the impact of related initiatives. When these terms are employed, they are often used interchangeably and/or not defined, which can lead to misunderstanding. This lack of a consistent, clear definition for these terms has been highlighted in outcomes research, pharmacoepidemiology, and related fields, as a barrier to implementing and measuring patient engagement in the field. The session was moderated by Rachel L. Harrington, BA, University of Illinois at Chicago, Chicago, IL, USA. Speakers included Eleanor M. Perfetto, PhD, MS, National Health Council, Washington, DC, USA and University of Maryland School of Pharmacy, Baltimore, MD, USA; Suzanne Schrandt, JD, Arthritis Foundation, Atlanta, GA, USA; and Sarah Donelson, MA, Genentech, San Francisco, CA, USA. In this session, speakers presented the proposed consensus definition of “patient engagement” suitable for use in the context of health economics and outcomes research. The proposed definition was derived from a multistep process that included a systematic review and qualitative analysis of existing definitions in addition to a multistakeholder review. The speakers shared the implications of and the response to a consensus definition for patient engagement from the perspective of key stakeholders, including patients, policy/research, and industry. The ISPOR Patient-Centered Special Interest Group, comprised of researchers and patient representatives, will submit a manuscript entitled, “Defining Patient Engagement in Research: Results of a Systematic Review and Analysis,” to the Society’s journal, Value in Health. Additional information on ISPOR 2018 can be found here. Released presentations from the conference can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORBaltimore.

###

  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg

Related Stories

ISPOR Chief Science Officer Dr Laura Pizzi Named to NJBIZ's 2026 People to Watch in Healthcare List

Jul 29, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) is proud to announce its Chief Science Officer, Laura Pizzi, PharmD, MPH, has been recognized by NJBIZ as one of its 2026 People to Watch in Healthcare.

ISPOR Publishes White Paper Focused on Systemic Coherence for Healthcare Decision Making in Europe

Jul 21, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that it has released a new white paper, “Achieving Systemic Coherence for Healthcare Decision Making in Europe.”

ISPOR Announces the Healthcare Investment Summit 2026

Jul 20, 2026

ISPOR announced their inaugural Healthcare Investment Summit 2026, which will bring together healthcare investors, founders, pharma and device executives, policy experts, health economists, and access leaders on September 22–23, 2026, in San Francisco to examine the critical factors shaping investment decisions across the healthcare landscape.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×